Filing Details
- Accession Number:
- 0001179110-11-006990
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-28 17:12:21
- Reporting Period:
- 2011-04-26
- Filing Date:
- 2011-04-28
- Accepted Time:
- 2011-04-28 17:12:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1308911 | E John Bishop | 675 West Kendall Street Cambridge MA 02142 | Senior Vp, Pharmaceutical Scie | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-04-26 | 7,034 | $18.86 | 99,642 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase stock | Acquisiton | 2011-04-26 | 2,343 | $12.81 | 2,343 | $12.81 |
| Common Stock | Option to purchase stock | Acquisiton | 2011-04-26 | 2,344 | $12.81 | 2,344 | $12.81 |
| Common Stock | Option to purchase stock | Acquisiton | 2011-04-26 | 2,347 | $12.81 | 2,347 | $12.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 137,519 | 2007-05-22 | 2017-02-22 | No | 4 | M | Direct |
| 135,175 | 2007-05-22 | 2017-02-22 | No | 4 | M | Direct |
| 132,828 | 2007-05-22 | 2017-02-22 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2009.
Billionaire Hedge Funds
